Premium
This is an archive article published on July 24, 2016

Universal flu vaccine comes closer to reality

Scientists at the National Institutes of Health (NIH) have identified three types of vaccine-induced antibodies that can neutralize diverse strains of influenza virus that infect humans.

Univerasl Flu vaccine, flu vaccine, National Institutes of Health, H5N1 influenza,flu virus stem, flu shots, influenza vaccine trials, Medical research, Medical research news, World news, latest news, International news The discovery will help guide development of a universal influenza vaccine, according to the investigators.

Every year, many people roll up their sleeves for a flu shot. Howbeit, the influenza virus has thousands of strains and the vaccine can’t guard against all of them. But now, a team of researchers finally might be onto something.

Scientists at the National Institutes of Health (NIH) have identified three types of vaccine-induced antibodies that can neutralize diverse strains of influenza virus that infect humans.

The discovery will help guide development of a universal influenza vaccine, according to the investigators.

Story continues below this ad

Until now, scientists had only identified broadly neutralizing antibodies targeting the flu virus stem in humans following natural infection. The new research provides clear evidence that these antibodies can be induced by a vaccine.

The researchers examined blood samples from six people who had received a vaccine against H5N1 influenza, commonly known as the bird flu virus.

In the blood samples they identified B cells (a type of white blood cell that responds to infection by secreting antibodies) that reacted to various subtypes of influenza virus, and then characterized and classified the cells’ antibody genetic sequences.

Watch Video: What’s making news

The scientists discovered the B cells encoded three classes of antibodies seen among multiple participants that can neutralize diverse influenza virus subtypes and, therefore, could form the basis of a universal flu vaccine.

Story continues below this ad

Researchers can now use the B cell sequencing information they identified to quickly and accurately measure immune responses among participants in future influenza vaccine trials, according to the authors.

The findings appear online in the journal Cell.


📣 For more lifestyle news, click here to join our WhatsApp Channel and also follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement